IMPORTANT INFORMATION FROM CIGNA
Interim COVID-19 coverage guidelines extended
Since the COVID-19 pandemic began, we have taken important steps to deliver timely accommodations to providers and customers, helping to ensure that customers have continued access to COVID-19 screening, testing, and treatment in safe settings.
Extending end dates
As previously announced, our interim COVID-19 coverage guidelines were set to expire on October 31, 2020. To further help ensure providers can continue to deliver care how and where patients want it, we are again extending our interim coverage guidelines, as follows:
- The cost-share waivers for COVID-19 diagnostic testing and related office visits are extended until January 21, 2021.
- The cost-share waiver for COVID-19 related treatment is extended until December 31, 2020.
- Most other interim accommodations (e.g., administrative relief policies) are extended until December 31, 2020.
Additional key updates
On October 30, 2020, we updated our dedicated COVID-19 provider web page to highlight the extended end dates for our interim coverage accommodations and to provide the latest information on a number of key topics, including our future-state Virtual Care Reimbursement Policy, our coverage and reimbursement of COVID-19 laboratory testing, and our coverage position for specific codes, including Z11.59 and 99072. We encourage you to visit the site to get all the latest information.
Thank you again for the quality care you provide and for all that you’re doing to help our customers and your community.